Fisher Asset Management, LLC’s Johnson & Johnson (JNJ) position
Reported position history, portfolio importance and verified filing changes from public SEC disclosures.
At a glance
The full verified relationship, including prior ownership episodes and exits where supported.
Fisher Asset Management, LLC first reported Johnson & Johnson in Q3 2021. The reported position was increased and reduced across later filings. Fisher Asset Management, LLC currently reports 13.31M shares. The latest verified filing showed: Bought 43.6% more.
Position over time
See the same verified relationship through reported shares, portfolio weight or reported value.
Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.
What changed
Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.
Filing context
Quarter-end price $253.97
Filing context
Quarter-end price $244.44
Filing context
Quarter-end price $206.95
Filing context
Quarter-end price $185.42
Filing context
Quarter-end price $152.75
Filing context
Quarter-end price $165.84
Filing context
Quarter-end price $144.62
Filing context
Quarter-end price $162.06
Filing context
Quarter-end price $146.16
Filing context
Quarter-end price $158.19
Filing context
Quarter-end price $156.74
Filing context
Quarter-end price $155.75
Filing context
Quarter-end price $165.52
Filing context
Quarter-end price $155.00
Filing context
Quarter-end price $0.18
Filing context
Quarter-end price $163.36
Filing context
Quarter-end price $177.51
Filing context
Quarter-end price $177.23
Filing context
Quarter-end price $171.07
Filing context
Quarter-end price $161.50
How important is Johnson & Johnson in Fisher Asset Management, LLC’s reported portfolio?
Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.
SEC filing evidence
Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.
Market context only; not an investor transaction price.
Derived from validated reported value and shares where supported.
View Johnson & Johnson stock page →
Coverage is bounded to the institution’s top reported positions and material events rather than every security in each Form 13F. The filing reflects reportable U.S.-listed holdings, not Fisher Investments’ complete global portfolio, client mandates, short positions, exact trade dates or execution prices. Options are reported separately.